Safety and efficacy of remote ischemic postconditioning after thrombolysis in patients with stroke.
Jia-Qi AnYa-Wen ChengYi-Chen GuoMeng WeiMin-Jie GongYong-Lan TangXing-Yun YuanWen-Feng SongChun-Ying MuAi-Feng ZhangArdan M SagunerGuo-Liang LiGuo-Gang LuoPublished in: Neurology (2020)
This study provides Class IV evidence that RIPC after tissue plasminogen activator treatment of AIS significantly increases the proportion of patients with an MRS score of 0 or 1 at 90 days.